Antonini A, Colosimo C, Marconi R, Morgante L, Barone P; PRIAMO study group. The PRIAMO study: background, methods and recruitment. Neurol Sci. 2008 Apr;29(2):61-5.
Barone P, Antonini A, Colosimo C, et al.; PRIAMO study group. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease Mov Disord. 2009 Aug 15;24(11):1641-9
Antonini A, Barone P, Marconi R, et al. The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life. J Neurol. 2012 Dec;259(12):2621-31.
Tinazzi M, Abbruzzese G, Antonini A, et al. Reasons driving treatment modification in Parkinson’s disease: results from the cross-sectional phase of the REASON study. Parkinsonism Relat Disord. 2013 Dec;19(12):1130-5
Beiske, A. G., et al. “Pain in Parkinson’s disease: prevalence and characteristics.” Pain 141.1 (2009): 173-177.
Chaudhuri, K., and Anthony HV Schapira. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. The Lancet Neurology 8.5 (2009): 464-474.
Poewe WH, Lees AJ, Stern GM. Low-dose L-dopa therapy in Parkinson’s disease: a 6-year follow-up study. Neurology 1986;36(11):1528-30.
Antonini A, Albin RL. Dopaminergic treatment and nonmotor features of Parkinson disease: the horse lives. Neurology 2013;80:784-5
Krishnan S, Sarma G, Sarma S, Kishore A. Do nonmotor symptoms in Parkinson’s disease differ from normal aging? Mov Disord 2011;26:2110-3.
Steiger M, Wong S, Crossley J, Fletcher N, Baker G, Wieshmann U. Are there non-motor symptoms specific to Parkinson’s disease? J Neurol Neurosurg Psychiatry 2013;84:e2
Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord [Internet]. 2011 Feb 15 [cited 2014];26(3):399-406
Müller B, Assmus J, Herlofson K, Larsen JP, Tysnes O-B. Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson’s disease. Parkinsonism Relat Disord [Internet]. Elsevier Ltd; 2013 Nov [cited 2014];19(11):1027-1032
Peto, V., Jenkinson, C., Fitzpatrick, (1998). PDQ-39: a review of the development , validation and application of a Parkinson ’ s disease quality of life questionnaire and its associated measures, J Neurol. 1998 May;245 Suppl 1:S10-4.
Lipnicki DM, Sachdev PS, Crawford J, et al. Risk factors for late-life cognitive decline and variation with age and sex in the Sydney Memory and Ageing Study. PLoS One [Internet]. 2013 Jan [cited 2014];8(6):e65841